304 related articles for article (PubMed ID: 28992290)
41. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.
Nucci M; Garnica M; Gloria AB; Lehugeur DS; Dias VC; Palma LC; Cappellano P; Fertrin KY; Carlesse F; Simões B; Bergamasco MD; Cunha CA; Seber A; Ribeiro MP; Queiroz-Telles F; Lee ML; Chauffaille ML; Silla L; de Souza CA; Colombo AL
Clin Microbiol Infect; 2013 Aug; 19(8):745-51. PubMed ID: 23009319
[TBL] [Abstract][Full Text] [Related]
42. Safety of anidulafungin in solid organ transplant recipients.
Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M;
Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
44. Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation.
Linke C; Ehlert K; Ahlmann M; Fröhlich B; Mohring D; Burkhardt B; Rössig C; Groll AH
Mycoses; 2020 Feb; 63(2):172-180. PubMed ID: 31661569
[TBL] [Abstract][Full Text] [Related]
45. Invasive fungal disease and cytomegalovirus infection: is there an association?
Yong MK; Slavin MA; Kontoyiannis DP
Curr Opin Infect Dis; 2018 Dec; 31(6):481-489. PubMed ID: 30299361
[TBL] [Abstract][Full Text] [Related]
46. Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
Rodríguez-Veiga R; Montesinos P; García E; Boluda B; Rojas R; Serrano J; Martínez-Cuadrón D; Martín C; Sanz J; Tabares S; Piñana JL; Lorenzo I; Montoro J; Salavert M; Pemán J; Jarque I; Solves P; Sanz GF; Torres A; Sanz MA
Mycoses; 2019 May; 62(5):418-427. PubMed ID: 30633829
[TBL] [Abstract][Full Text] [Related]
47. Invasive fungal disease in children with solid tumors: An Australian multicenter 10-year review.
Jain N; Ryan AL; Haeusler GM; McMullan BJ; Moore AS; Bartlett AW; Blyth CC; Kotecha RS; Yeoh DK; Clark JE
Pediatr Blood Cancer; 2024 Jul; 71(7):e31031. PubMed ID: 38679843
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.
Liu J; Huang H; Li Y; Liu L; Li J; Liu Z; Lu J; Ouyang J; Song Y; Zhou D; Ren H; Ma J; Wang C; Yu L; Zhou J; Wang J; Xiao Y; Huang X; Li J
Tumour Biol; 2016 Jun; 37(6):7893-900. PubMed ID: 26700667
[TBL] [Abstract][Full Text] [Related]
49. Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant.
Zhang X; Zhang L; Li Y; Wang N; Zhang Y
Front Cell Infect Microbiol; 2024; 14():1210857. PubMed ID: 38590441
[TBL] [Abstract][Full Text] [Related]
50. Outcomes of solid organ transplant recipients with invasive aspergillosis and other mold infections.
Farges C; Cointault O; Murris M; Lavayssiere L; Lakhdar-Ghazal S; Del Bello A; Hebral AL; Esposito L; Nogier MB; Sallusto F; Iriart X; Charpentier E; Guitard J; Muscari F; Dambrin C; Porte L; Kamar N; Cassaing S; Faguer S
Transpl Infect Dis; 2020 Feb; 22(1):e13200. PubMed ID: 31630477
[TBL] [Abstract][Full Text] [Related]
51. Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation.
Ceesay MM; Kordasti S; Rufaie E; Lea N; Smith M; Wade J; Douiri A; Mufti GJ; Pagliuca A
J Infect; 2016 Sep; 73(3):280-8. PubMed ID: 27343564
[TBL] [Abstract][Full Text] [Related]
52. [Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections].
Lichtenstern C; Pratschke J; Schulz U; Schmoeckel M; Knitsch W; Kaskel P; Krobot KJ; Weigand MA; Winkler M
Anaesthesist; 2010 Dec; 59(12):1083-90. PubMed ID: 21069271
[TBL] [Abstract][Full Text] [Related]
53. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
[TBL] [Abstract][Full Text] [Related]
54. Complications of invasive mycoses in organ transplant recipients.
Samanta P; Singh N
Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1195-1202. PubMed ID: 27690694
[TBL] [Abstract][Full Text] [Related]
55. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.
Vehreschild JJ; Rüping MJ; Steinbach A; Cornely OA
Expert Opin Pharmacother; 2010 Jan; 11(1):95-113. PubMed ID: 20001432
[TBL] [Abstract][Full Text] [Related]
57. A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.
Takagi S; Araoka H; Uchida N; Uchida Y; Kaji D; Ota H; Nishida A; Ishiwata K; Tsuji M; Yamamoto H; Ito T; Matsuno N; Yamamoto G; Asano-Mori Y; Hayashi M; Izutsu K; Masuoka K; Wake A; Makino S; Yoneyama A; Taniguchi S
Int J Hematol; 2014; 99(5):652-8. PubMed ID: 24664791
[TBL] [Abstract][Full Text] [Related]
58. [Evaluation of the prescription, consumption and costs of antifungal drugs in a pediatric hospital in Chile].
Barraza M; Barnafi N; Ortiz G; Torres JP; Coria P; Catalán P; Palma J; Morales J
Rev Chilena Infectol; 2018 Aug; 35(4):351-357. PubMed ID: 30534920
[TBL] [Abstract][Full Text] [Related]
59. Invasive fungal diseases in patients with new diagnosed acute lymphoblastic leukaemia.
Gründahl M; Wacker B; Einsele H; Heinz WJ
Mycoses; 2020 Oct; 63(10):1101-1106. PubMed ID: 32738006
[TBL] [Abstract][Full Text] [Related]
60. Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review.
Yeoh DK; Moore AS; Kotecha RS; Bartlett AW; Ryan AL; Cann MP; McMullan BJ; Thursky K; Slavin M; Blyth CC; Haeusler GM; Clark JE
Pediatr Blood Cancer; 2021 Nov; 68(11):e29275. PubMed ID: 34357688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
